Health
Medical
Cancer Prevention

Cancer Genetics

$0.2605
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0055 (-2.07%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell CGIX and other stocks, options, ETFs, and crypto commission-free!

About

Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomaker solutions, biorepository solutions, consulting, cytogenetics testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. Read More The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.

Employees
245
Headquarters
Rutherford, New Jersey
Founded
1999
Market Cap
7.22M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
890.73K
High Today
$0.2728
Low Today
$0.2561
Open Price
$0.27
Volume
455.43K
52 Week High
$1.85
52 Week Low
$0.20

Collections

Health
Medical
Cancer Prevention
Consulting
Business Services
2013 IPO
US
North America

News

MarketBeatMar 7

Stock Price, News, & Analysis for Cancer Genetics

Cancer Genetics, Inc. develops, commercializes, and provides molecular and biomarker-based tests and services in the United States, Europe, and Asia. Its tests enable physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor, and inform cancer treatment; and enable biotech and pharmaceutical companies involved in oncology and immuno-oncology trials to select candidate populations and reduce adverse drug reactions by providing informati...

182
Simply Wall StMar 7

How Does Cancer Genetics, Inc. (NASDAQ:CGIX) Affect Your Portfolio Volatility?

Anyone researching Cancer Genetics, Inc. (NASDAQ:CGIX) might want to consider the historical volatility of the share price. Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. The first type is company specific volatility. Investors use diversification across uncorrelated stocks to reduce this kind of price volatility across the portfolio. The second type is the broader market volatility, which you cannot diversify away, since it arises from ...

952

Earnings

-$0.31
-$0.24
-$0.18
-$0.11
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.